The Rosetta Stone by Anne Miranda

अब Quizwiz के साथ अपने होमवर्क और परीक्षाओं को एस करें!

hieroglyphics

5000 year old Egyptian writing system

pharaoh

Egyptian ruler

necessity of language to civilization

In order for people to cooperate, they must be able to communicate.

cartouche

a symbol in which the names of pharaohs were written

British Museum

current location of the Rosetta Stone

bottom of the Rosetta Stone

inscribed with Greek

middle of the Rosetta Stone

inscribed with demotic (type of Egyptian writing)

top of the Rosetta Stone

inscribed with hieroglyphics

Nile River

land along where the Egyptians settled

Rosetta Stone

large basalt rock upon which three languages were inscribed

reason why ancient Egyptian can't be spoken

no written vowels in hieroglyphics

1000 to 6000

number of symbols or characters in hieroglyphic writing system

14

number of years it took one person to decipher the Rosetta Stone

Ancient Egypt

one of the earliest civilizations in the world

Ptolemy V

pharaoh of Egypt at the time of the creation of the Rosetta Stone

phonograms

symbols that represent sounds

ideograms

symbols that represent whole words or ideas

the British

the current "owners" of the Rosetta Stone

Jean-Francois Champollion

the man who deciphered the Rosetta Stone

the French

the people who discovered the Rosetta Stone

1798 AD (BONUS)

the year the French invaded Egypt (BONUS)

1822 AD (BONUS)

the year the Rosetta Stone was deciphered (BONUS)

1799 AD (BONUS)

the year the Rosetta Stone was discovered by the French (BONUS)

1801 AD (BONUS)

when the British drove the French out of Egypt and took possession of the Rosetta Stone (BONUS)

196 BC (BONUS)

when the Rosetta Stone was created (BONUS)


संबंधित स्टडी सेट्स

MEGA/MOCA exam social studies flash cards elementary education multi-content

View Set

Maternal newborn [OB] proctored with choices

View Set

Chapter 13-Advanced PowerPoint Features

View Set

Message Factors (Factors Influencing Persuasive Effectiveness)

View Set

Chapter 33: Management of Patients With Nonmalignant Hematologic Disorders 4

View Set